Transforming growth factor‐beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-5491|19|6|440-447

ISSN： 0742-3071

Source： DIABETIC MEDICINE, Vol.19, Iss.6, 2002-06, pp. : 440-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression Changes of Transforming Growth Factor-Beta1 and Thrombospondin-1 in Cavernous Tissues of Diabetic Rats

By  

Urologia Internationalis, Vol. 84, Iss. 2, 2010-03 ,pp. : 221-225

Karger

Access to resources Recommend Favorite

Transforming Growth Factor-Beta-1 Variants Are Not Associated with Chronic Nonalcoholic Pancreatitis

By  

Pancreatology, Vol. 5, Iss. 1, 2005-04 ,pp. : 75-80

Karger

Access to resources Recommend Favorite

Connective Tissue Growth Factor Does Not Affect Transforming Growth Factor-Beta 1-Induced Smad3 Phosphorylation and T Lymphocyte Proliferation Inhibition

By  

International Archives of Allergy and Immunology, Vol. 147, Iss. 2, 2008-06 ,pp. : 152-160

Karger

Access to resources Recommend Favorite

Efficacy of topical epidermal growth factor in healing diabetic foot ulcers

By Afshari Mojgan   Larijani Bagher   Fadayee Monireh   Ghahary Aziz   Pajouhi Mohammad   Bastanhagh Mohammad-Hassan   Baradar-Jalili Reza   Vassigh Ali-Reza   Darvishzadeh Farzaneh  

Therapy, Vol. 2, Iss. 5, 2005-09 ,pp. : 759-765

Future Medicine

Access to resources Recommend Favorite

Examining Potential Therapies Targeting Myocardial Fibrosis through the Inhibition of Transforming Growth Factor-Beta 1

By  

Cardiology, Vol. 108, Iss. 4, 2007-02 ,pp. : 368-380

Karger

Access to resources Recommend Favorite